The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Homologous recombination deficiency (HRD) by BROCA-HR and survival outcomes after surgery for patients (pts) with pancreatic adenocarcinoma (PC): A single institution experience.
 
Amy E. Chang
No Relationships to Disclose
 
David Bing Zhen
No Relationships to Disclose
 
Marc Radke
No Relationships to Disclose
 
Kelsey K. Baker
No Relationships to Disclose
 
Andrew L. Coveler
Consulting or Advisory Role - Abbvie; Abbvie; Abbvie; Abbvie; Halozyme; Halozyme; Halozyme; Halozyme; Merrimack; Merrimack; Merrimack; Merrimack; Seagen; Seagen; Seagen; Seagen
Research Funding - AbGenomics International (Inst); AbGenomics International (Inst); AbGenomics International (Inst); AbGenomics International (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Amgen (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Genentech (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Gilead Sciences (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Immunomedics (Inst); Immunomedics (Inst); Immunomedics (Inst); Immunomedics (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); MedImmune (Inst); Newlink Genetics (Inst); Newlink Genetics (Inst); Newlink Genetics (Inst); Newlink Genetics (Inst); Novocure (Inst); Novocure (Inst); Novocure (Inst); Novocure (Inst); Onconova Therapeutics (Inst); Onconova Therapeutics (Inst); Onconova Therapeutics (Inst); Onconova Therapeutics (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); Taiho Pharmaceutical (Inst); XBiotech (Inst); XBiotech (Inst); XBiotech (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - Abbvie; Abbvie; Abbvie; Abbvie; Halozyme; Halozyme; Halozyme; Halozyme
 
Kit Man Wong
Research Funding - Adaptimmune; Adaptimmune; Adaptimmune; Adaptimmune; Astellas Pharma; Astellas Pharma; Astellas Pharma; Astellas Pharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Genentech; Genentech; Genentech; Genentech; Mitsubishi Tanabe Pharma; Mitsubishi Tanabe Pharma; Mitsubishi Tanabe Pharma; Mitsubishi Tanabe Pharma; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Pfizer; Replimune; Replimune; Replimune; Replimune; Shanghai Denovo; Shanghai Denovo; Shanghai Denovo; Shanghai Denovo
 
Venu Gopal Pillarisetty
Consulting or Advisory Role - GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Imvax; Imvax; Imvax; Imvax; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme
Research Funding - AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); AstraZeneca/MedImmune (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Ipsen (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; GlaxoSmithKline; Imvax; Imvax; Imvax; Imvax; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme; Merck Sharp & Dohme
 
Mary Weber Redman
Consulting or Advisory Role - Ignyta; Ignyta; Ignyta; Ignyta; Ignyta; Ignyta; Ignyta; Ignyta
 
Elizabeth Swisher
Consulting or Advisory Role - IDEAYA Biosciences; IDEAYA Biosciences; IDEAYA Biosciences; IDEAYA Biosciences
Expert Testimony - Johnson & Johnson; Johnson & Johnson; Johnson & Johnson; Johnson & Johnson
 
E. Gabriela Chiorean
Consulting or Advisory Role - Array BioPharma; Array BioPharma; Array BioPharma; Array BioPharma; AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Celgene; Celgene; Celgene; Celgene; Eisai; Eisai; Eisai; Eisai; Five Prime Therapeutics; Five Prime Therapeutics; Five Prime Therapeutics; Five Prime Therapeutics; Halozyme; Halozyme; Halozyme; Halozyme; Ipsen; Ipsen; Ipsen; Ipsen; Seagen; Seagen; Seagen; Seagen; Vicus Therapeutics; Vicus Therapeutics; Vicus Therapeutics; Vicus Therapeutics
Research Funding - AADi (Inst); AADi (Inst); AADi (Inst); AADi (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Celgene (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Halozyme (Inst); Ignyta (Inst); Ignyta (Inst); Ignyta (Inst); Ignyta (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Incyte (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); Lilly (Inst); MacroGenics (Inst); MacroGenics (Inst); MacroGenics (Inst); MacroGenics (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Merck (Inst); Rafael Pharmaceuticals (Inst); Rafael Pharmaceuticals (Inst); Rafael Pharmaceuticals (Inst); Rafael Pharmaceuticals (Inst); Stemline Therapeutics (Inst); Stemline Therapeutics (Inst); Stemline Therapeutics (Inst); Stemline Therapeutics (Inst)
Travel, Accommodations, Expenses - AstraZeneca; AstraZeneca; AstraZeneca; AstraZeneca; Seagen; Seagen; Seagen; Seagen